TABLE 2.
Prognostic value of 12 hub genes in the cervical cancer patients of the TCGA cohort.
| Hub genes | Univariate cox analysis | Multivariate cox analysis | Coefficient | ||
|---|---|---|---|---|---|
| Hazard ratio (95% CI) | p-value | Hazard ratio (95% CI) | p-value | ||
| CXCL1 | 2.29 (1.40–3.76) | 0.033* | 1.13 (1.00–1.27) | 0.174 | 0.1181 |
| CXCL9 | 0.42 (0.22–0.80) | 0.077 | 0.91 (0.83–1.01) | 0.071 | -0.0908 |
| CXCL10 | 0.63 (0.39–1.01) | 0.160 | 0.95 (0.86–1.04) | 0.250 | -0.0560 |
| CXCL13 | 0.55 (0.35–0.88) | 0.360 | 0.94 (0.86–1.02) | 0.129 | -0.0667 |
| STAT1 | 0.65 (0.40–1.03) | 0.330 | 0.90 (0.7–1.13) | 0.370 | -0.1043 |
| TLR2 | 0.58 (0.35–0.96) | 0.180 | 0.85 (0.69–1.06) | 0.160 | -0.1578 |
| ANLN | 1.77 (1.10–2.83) | 0.087 | 1.46 (1.03–2.07) | 0.341 | 0.3790 |
| CCNB1 | 0.59 (0.37–0.96) | 0.320 | 0.87 (0.57–1.31) | 0.493 | -0.1450 |
| CHEK1 | 0.80 (0.49–1.30) | 0.910 | 1.08 (0.71–1.65) | 0.715 | 0.0784 |
| RRM2 | 1.40 (0.87–2.26) | 0.029* | 1.22 (0.81–1.83) | 0.034* | 0.2560 |
| TYMS | 0.47 (0.29–0.77) | 0.041* | 0.76 (0.52–1.12) | 0.048* | -0.3332 |
| UBE2C | 0.75 (0.45–1.26) | 0.510 | 1.00 (0.67–1.49) | 0.997 | 8.00E-04 |
“*” represents p < 0.05.